financetom
Business
financetom
/
Business
/
Garrett Motion Declares Cash Dividend, Approves New Stock Buyback Program; Shares Up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Garrett Motion Declares Cash Dividend, Approves New Stock Buyback Program; Shares Up
Dec 5, 2024 7:15 AM

09:47 AM EST, 12/05/2024 (MT Newswires) -- Garrett Motion ( GTX ) said Thursday its board declared a Q1 2025 dividend of $0.06 per share, payable Jan. 31 to shareholders of record Jan. 15.

The company said the board also approved a $250 million share repurchase program for 2025.

Garrett said the dividend and the buyback are part of its long-term capital allocation framework, under which it will target returning at least 75% of its adjusted free cash flow to shareholders over time.

The company's shares rose 7% in recent trading.

Price: 9.19, Change: +0.60, Percent Change: +6.98

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UBS Raises Its Eurozone GDP Growth Forecasts Slightly This Year, Lowers for 2025
UBS Raises Its Eurozone GDP Growth Forecasts Slightly This Year, Lowers for 2025
Oct 7, 2024
08:26 AM EDT, 10/07/2024 (MT Newswires) -- UBS said it raised its eurozone gross domestic product growth forecast by 0.1pp to 0.7% for this year while the consensus is for 0.7%, given stronger-than-expected growth in H1 2024. At the same time, the bank cut its 2025 GDP forecast by 0.3pp to 0.9% while the consensus is for 1.3%, given a...
OPKO Health's ModeX Receives $35 Million in Federal Funding for Covid, Flu Vaccine Development
OPKO Health's ModeX Receives $35 Million in Federal Funding for Covid, Flu Vaccine Development
Oct 7, 2024
08:29 AM EDT, 10/07/2024 (MT Newswires) -- OPKO Health ( OPK ) subsidiary ModeX Therapeutics said Monday it has been awarded an additional $35 million in funding under a contract with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority to develop Covid-19 and flu vaccines. The company said it will use the funding to...
Ultragenyx's Setrusumab Receives FDA Breakthrough Therapy Designation
Ultragenyx's Setrusumab Receives FDA Breakthrough Therapy Designation
Oct 7, 2024
08:28 AM EDT, 10/07/2024 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Monday that the US Food and Drug Administration has granted breakthrough therapy designation for setrusumab to reduce the risk of fracture in patients with osteogenesis imperfecta. The designation covers treatment for patients aged two years and older with type 1, type 3 or type 4 osteogenesis imperfecta,...
Rocket Lab Wins NASA Study Contract For Mars Mission: Details
Rocket Lab Wins NASA Study Contract For Mars Mission: Details
Oct 7, 2024
Rocket Lab USA, Inc. ( RKLB ) shares are trading higher premarket on Monday. The company disclosed that NASA has selected the company to conduct a study on retrieving rock samples from the Martian surface and returning them to Earth. This mission aims to address key solar system exploration objectives, enhancing the company’s understanding of Mars, potentially determining if life...
Copyright 2023-2026 - www.financetom.com All Rights Reserved